In 1998, Moulard et al. identified homozygous deletions of SMN2 in 36% of individuals with sporadic adult-onset lower motor neuron disease, but in only 6.2% of individuals with sporadic ALS and in 1.5% of individuals with familial ALS [11]. Here, SMN2 is linked to amyotrophic lateral sclerosis.